Exploring Motor Learning in Acute Stroke Through Robotics

Stroke, Acute Clinical Trial

Official title:

Exploring Motor Learning in Acute Stroke Through Robotics

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04171856
• Other study ID #: B039201938990
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2020
• Est. completion date: July 1, 2040

Study information

• Verified date: January 2024
• Source: University Hospital of Mont-Godinne
• Contact: Yves Vandermeeren, MD, PhD
• Phone: +32 81 42 33 21
• Email: yves.vandermeeren[@]uclouvain.be
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor skills with their affected upper limb. The aims of this research program are:

1. To test the capacity of acute stroke patients (< 21 days) to learn and retain a complex unimanual motor skill.

2. To explore whether acute stroke to different brain regions (quantified with brain MRI) induces specific deficits in motor skill learning.

3. To compare acute stroke patients with healthy individuals and with chronic stroke patients.

Description:

Over 3 consecutive days, the subjects will be evaluated and will train on the rehabilitation robot REAplan® (http://www.axinesis.com/). They will practice 2 serious games on the robot.

In order to differentiate the effect of motor control recovery from that of MskL, the acute stroke patients will be randomised 4/1 to "MskL" (n=120) ,to "motor control recovery" (n=30) or to "conventional" group (n=15) with a minimisation software. The experimental design will be similar except that the "motor control recovery" group will practice the serious game EASY instead of CIRCUIT (see below) and the "conventional" group will practice conventional therapy instead of CIRCUIT. The performances on both EASY & CIRCUIT will be compared between groups (subjects in both groups will perform the EASY & CIRCUIT tasks).The total time of rehabilitation will be the same.

The motor skill learning setup (CIRCUIT + EASY) that we developed and successfully used in healthy individuals and stroke patients has already been implemented in the REAplan environment and will be used as innovative serious games based on a speed/accuracy trade-off (SAT), allowing a detailed analysis of motor skill learning components (speed, accuracy, SAT, movement smoothness, dynamics...). For the serious game CIRCUIT, who based on motor skill learning, the subjects will have to practice a complex circuit and move as a cursor quickly and accurately as possible by controlling the handle of the robot with their affected hand/arm. For the other task EASY (a brick busters serious game), the aim will be to go back and forth between walls presented in different locations. The CONVENTIONAL therapy will consist in classical exercices focused in the upper limb administered by occupational therapist.

The subacute stroke phase is a unique opportunity to investigate the role of brain structures in motor learning/control. Compared to chronic impairments (> 6 months post-stroke), the subacute phase provides a window into how a lesion perturbs sensorimotor functions prior to reorganisation driven by plasticity and neurorehabilitation. To clarify the role of different brain structures in MskL, Voxel-based Lesion Symptom Mapping (VLSM) based on high-resolution brain magnetic resonance imaging (MRI) scans, will be used to analyse the relationship between tissue damage and MskL scores on a voxel-by-voxel basis.

In addition, several "classical" clinical scales and tests will be used to evaluate overall motor-sensory-cognitive functions. The subjects will practice serious games on the robot REAplan (R), requiring movements with the affected arm (unimanual tasks).

And, we used a Dextrain® tool which allows quantification of key components of manual dexterity : forces, selectivity (independance of fingers movement) and coactivation of the fingers.Moreover, we added a Transcranial magnetic stimulation (TMS), as a tool for predicting recovery of motor function after stroke.

In addition to the (sub)acute stroke patients, 4 others groups will be recruited for this study : a group of acute stroke patients who will receive "conventional rehabilitation" and be shortly tested on the robot (N=15), a group of chronic stroke patients (stroke > 6 months) who will not be hospitalized and will not undergo MRI (N=30), a group of healthy individuals who will not undergo MRI (N=50) and a group of patients with a transient global amnesia which is a sudden, temporary episode (<24hours) of memory loss (N=15).

Subjects in these 4 groups will be randomized 1/1 in the two arms ("MSkL" versus "motor control recovery" arms), except the patients with a TGA who will be included in the "MSkL" arm only.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 245
• Est. completion date: July 1, 2040
• Est. primary completion date: May 1, 2030
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

ACUTE STROKE PATIENTS:

Inclusion Criteria:

• acute stroke (> 21 days)

• aged 18-90 years

• with a stroke lesion on brain imaging

Exclusion Criteria:

• " classical " contre-indication to MRI (non-MR-compatible pacemaker, pregnancy, non-MR-compatible implanted devices, claustrophoby, etc ...)

• difficulty in understanding or executing commands

• drug/alcohol abuse

• severe aphasia / cognitive deficits interfering with study

• inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)

• multiple strokes / dementia / psychiatric condition

PATIENTS WITH TRANSIENT GLOBAL AMNESIA:

Clinical diagnosis, criteria of Hodge & Warlow (1990):

• Anterograde amnesia observed by a witness

• No alteration of consciousness or loss of identity

• Cognitive dysfunction limited to amnesia

• Lack of focused neurological deficit or argument for a comitiality

• Absence of head trauma

• Symptom resolution within 24 hours

• Possible existence of vegetative symptoms

Inclusion criteria:

• Transient global amnesia

• 8-90 years old

• Be able to perform 3 consecutive sessions on a rehabilitation robot

Exclusion criteria:

• Severe aphasia / cognitive deficits interfering with study

• Psychiatric disorders

• Alcohol / drug addiction

• Exclusion criteria related to MRI

HEALTHY INDIVIDUALS:

Inclusion Criteria:

• 18-90 years

Exclusion Criteria:

• medical history with a previous stroke/neurological deficit

• drug/alcohol abuse

• psychiatric condition/ dementia

CHRONIC STROKE PATIENTS:

Inclusion Criteria:

• chronic stroke (>6 months)

• aged 18-90 years

• with a stroke lesion on brain imaging

Exclusion Criteria:

• difficulty in understanding or executing commands

• drug/alcohol abuse

• severe aphasia / cognitive deficits interfering with study

• inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)

• multiple strokes / dementia / psychiatric condition

Related Conditions & MeSH terms

• Stroke
• Stroke, Acute

Intervention

Device:
• REAplan(R)
motor skill learning with the REAplan(R) rehabilitation robot, to be perfomed with the affected arm

Locations

Country	Name	City	State
Belgium	CHU UCL Namur	Yvoir	Namur
Belgium	University Hospital CHU Dinant Godinne UCL	Yvoir

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital of Mont-Godinne

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in SAT (CIRCUIT)	Speed/ Accuracy Trade-off	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Primary	total distance travelled (EASY)	total distance travelled between the walls of the brick busters (in cm)	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary	Fugl Meyer Upper Extremity Test	Tests impairments of the upper limb after stroke	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary	Arm Motor Ability (AMA) test	Measure disabilities of the upper limb after stroke	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary	Fatigue Visual Analog Scale (VAS)	Visual Analog Scale to evaluate fatigue between 0 and 10. The maximum value (10) indicate a high level of fatiguability.	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary	Voxel-based Lesion Symptom Mapping (VLSM)	High-resolution 3D-MRI, diffusion MRI (DWI) & perfusion MRI (PWI with Arterial SPin Labelling technique) will be acquired. The stroke areas will be drawn with MRIcron as volumes of interest (VOI) in native space and compared.	Baseline
Secondary	Dextrain®	Quantitative assessment of the manual dexterity : fingers strength and selectivity, coactivation.	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary	Grober and Buschke test (16 items) (for patients with trasient global amnesia)	Assessement of episodic verbal memory	Baseline
Secondary	Brief Visuospatial Memory Test-Revised	Measure of visuospatial memory (for patients with trasient global amnesia)	Baseline
Secondary	Forces of the upper limb on the REAplan robot (CIRCUIT, EASY, REACHING)	To evaluate the Force of the upper limb after stroke (Newton)	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary	Spectral Arc Lenght on the REAplan robot (CIRCUIT, EASY, REACHING)	Movement smoothness quantification	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary	Total distance of the upper limb on the REAplan robot (CIRCUIT, EASY, REACHING)	Measure of total distance traveled during the training (cm)	change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary	transcranial magnetic stimulation (TMS)	Measure of the prediction recovery after stroke	correlation with the measure realized Day 1 with progression of the motor skill learning (change between Baseline Day1 and Day 3)